We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+1.38%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$23.9B
AUM Growth
-$469M
(-1.9%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
1,935
New
209
Increased
532
Reduced
683
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$392M |
| 2 |
BP
BP
|
+$158M |
| 3 |
General Motors
GM
|
+$152M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$148M |
| 5 |
Amdocs
DOX
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$102M |
| 2 |
Marriott International
MAR
|
+$95.6M |
| 3 |
Fortinet
FTNT
|
+$94.9M |
| 4 |
Cardinal Health
CAH
|
+$91.3M |
| 5 |
Apple
AAPL
|
+$88.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.31% |
| 2 | Consumer Discretionary | 13.19% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Staples | 10.22% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Neurocrine Biosciences
NBIX
$16.8B
| $5.26M | 0.02% |
46,772
+22,741
| +95% | +$2.39M |
|
427
Advanced Micro Devices
AMD
$767B
| $5.24M | 0.02% |
50,952
+22,857
| +81% | +$2.48M |
|
428
Zymeworks
ZYME
$1.71B
| $5.23M | 0.02% |
825,988
+727,934
| +742% | +$5.38M |
|
429
State Street
STT
$51.3B
| $5.23M | 0.02% |
78,115
+76,769
| +5,703% | +$5.41M |
|
430
Northrim BanCorp
NRIM
$588M
| $5.17M | 0.02% |
522,116
| – | – |
|
431
Blue Owl Capital
OBDC
$5.7B
| $5.14M | 0.02% |
371,073
+371,030
| +862,860% | +$5.12M |
|
432
Intuit
INTU
$91.5B
| $5.06M | 0.02% |
9,921
+5,374
| +118% | +$2.72M |
|
433
Rigel Pharmaceuticals
RIGL
$778M
| $5.03M | 0.02% |
466,074
+7,923
| +2% | +$95.3K |
|
434
Matsons
MATX
$6.24B
| $5M | 0.02% |
56,335
-61,029
| -52% | -$5.33M |
|
435
Everspin Technologies
MRAM
$388M
| $4.98M | 0.02% |
507,115
+73,109
| +17% | +$707K |
|
436
Tower Semiconductor
TSEM
$28.5B
| $4.97M | 0.02% |
202,945
+199,823
| +6,400% | +$6.41M |
|
437
McDonald's
MCD
$194B
| $4.97M | 0.02% |
18,872
-26,239
| -58% | -$7.48M |
|
438
BlueLinx
BXC
$719M
| $4.96M | 0.02% |
60,398
-33,492
| -36% | -$2.94M |
|
439
NETGEAR
NTGR
$627M
| $4.96M | 0.02% |
393,938
+44,911
| +13% | +$596K |
|
440
Ooma
OOMA
$593M
| $4.95M | 0.02% |
380,860
+33,519
| +10% | +$474K |
|
441
Franco-Nevada
FNV
$46.5B
| $4.9M | 0.02% |
36,600
+27,100
| +285% | +$3.83M |
|
442
Bassett Furniture
BSET
$169M
| $4.9M | 0.02% |
334,447
-14,714
| -4% | -$230K |
|
443
Puma Biotechnology
PBYI
$449M
| $4.88M | 0.02% |
1,858,000
-16,123
| -0.9% | -$54.9K |
|
|
SVM
444
Silvercorp Metals
SVM
$2.7B
| $4.88M | 0.02% |
2,096,973
-1,051,020
| -33% | -$2.85M |
|
445
Voyager Therapeutics
VYGR
$195M
| $4.88M | 0.02% |
630,163
-89,496
| -12% | -$817K |
|
446
Newmont
NEM
$124B
| $4.88M | 0.02% |
132,124
-80,140
| -38% | -$3.26M |
|
447
Ezcorp Inc
EZPW
$1.67B
| $4.87M | 0.02% |
589,904
+12,841
| +2% | +$110K |
|
448
Natural Resource Partners
NRP
$1.39B
| $4.84M | 0.02% |
61,328
-2,434
| -4% | -$158K |
|
449
TAL Education Group
TAL
$6.93B
| $4.8M | 0.02% |
527,749
+292,884
| +125% | +$2.05M |
|
450
Owens Corning
OC
$12.2B
| $4.78M | 0.02% |
35,091
+34,515
| +5,992% | +$4.74M |
|
Similar funds
Acadian Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Acadian Asset Management held 1,935 positions worth $23.9B, down 1.9% from $24.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Acadian Asset Management's Q3 2023 filing shows 209 new, 532 increased, 683 reduced and 293 closed positions. Its largest new stake was Amdocs: 1,147,499 shares worth $96.9M. The largest sale was GSK, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Acadian Asset Management's largest Q3 2023 buy was Amdocs: 1,147,499 shares worth $96.9M.
- Acadian Asset Management added most to Stellantis in Q3 2023, an estimated $392M increase.
- Acadian Asset Management's biggest Q3 2023 reduction was GSK, cutting an estimated $102M.
- Acadian Asset Management fully exited KE Holdings in Q3 2023, selling an estimated $49.5M.
- Acadian Asset Management's ten largest holdings make up 21% of its $23.9B portfolio in Q3 2023.
- Acadian Asset Management opened 209 new positions and closed 293 in Q3 2023.
- Acadian Asset Management's portfolio value fell 1.9% quarter-over-quarter to $23.9B.
Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.